AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / GRAIN MILL PRODUCTS
Genmab A/S ADS
XNAS · usd
SIC 8732 · GRAIN MILL PRODUCTS
FIGI BBG004MPKMY3
43.79▲ 3.79 (9.47%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
40.00
Day's Range
39.64 – 44.34
52-Week Range
23.62 – 44.34
Volume
12.6M
Avg Volume
4.1M
Share Statistics
Shares Outstanding
Employees
3,029
Exchange
XNAS
Listed
2010-10-05
Share count as of December 31, 2025

Genmab A/S ADS (GMAB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Genmab A/S ADS (GMAB)
What is Genmab A/S ADS's Market Cap?
Genmab A/S ADS's Market Cap is $5.6B, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Enterprise Value?
Genmab A/S ADS's Enterprise Value is $4.3B, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Trailing P/E?
Genmab A/S ADS's Trailing P/E is 5.2×, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Price / Sales?
Genmab A/S ADS's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's EV / Revenue?
Genmab A/S ADS's EV / Revenue is 1.4×, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Revenue (TTM)?
Genmab A/S ADS's Revenue (TTM) is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Net Income (TTM)?
Genmab A/S ADS's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Diluted EPS (TTM)?
Genmab A/S ADS's Diluted EPS (TTM) is 8.47, based on as-reported figures from SEC (XBRL) filings.
What is Genmab A/S ADS's Net Debt?
Genmab A/S ADS's Net Debt is -$1.4B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GMABAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2019Dec 31, 2018Dec 31, 2017
Profit or loss [abstract]
Revenue
Cost of product sales
Research and development expenses
Selling, general and administrative expenses
Acquisition and integration related charges
Total costs and operating expenses
Operating profit
Financial income
Financial expenses
Net profit before tax
Corporate tax
Net profit
Amounts which may be re-classified to the income statement:
Exchange differences on translation of foreign operations
Total comprehensive income
Basic net profit per share (in dollars per share)
Diluted net profit per share (in dollars per share)